nodes	percent_of_prediction	percent_of_DWPC	metapath
Flupentixol—ADRA1A—polycystic ovary syndrome	0.826	1	CbGaD
Flupentixol—Quetiapine—ADRA1D—polycystic ovary syndrome	0.00106	0.249	CrCbGaD
Flupentixol—Zuclopenthixol—ADRA1A—polycystic ovary syndrome	0.00106	0.248	CrCbGaD
Flupentixol—Quetiapine—ADRA1B—polycystic ovary syndrome	0.000906	0.213	CrCbGaD
Flupentixol—DDC—embryo—polycystic ovary syndrome	0.000704	0.148	CbGeAlD
Flupentixol—Trifluoperazine—ADRA1A—polycystic ovary syndrome	0.000629	0.148	CrCbGaD
Flupentixol—HTR2A—urine—polycystic ovary syndrome	0.000624	0.131	CbGeAlD
Flupentixol—Quetiapine—ADRA1A—polycystic ovary syndrome	0.00061	0.143	CrCbGaD
Flupentixol—DDC—adrenal gland—polycystic ovary syndrome	0.000417	0.0873	CbGeAlD
Flupentixol—DDC—endocrine gland—polycystic ovary syndrome	0.000361	0.0757	CbGeAlD
Flupentixol—ADRA1A—adipose tissue—polycystic ovary syndrome	0.000206	0.0431	CbGeAlD
Flupentixol—DRD2—pituitary gland—polycystic ovary syndrome	0.000202	0.0424	CbGeAlD
Flupentixol—HTR2A—embryo—polycystic ovary syndrome	0.000202	0.0423	CbGeAlD
Flupentixol—CHRM1—endocrine gland—polycystic ovary syndrome	0.000195	0.0408	CbGeAlD
Flupentixol—ADRA1A—adrenal gland—polycystic ovary syndrome	0.000185	0.0387	CbGeAlD
Flupentixol—ADRA1A—endocrine gland—polycystic ovary syndrome	0.00016	0.0335	CbGeAlD
Flupentixol—DRD2—endocrine gland—polycystic ovary syndrome	0.000157	0.0329	CbGeAlD
Flupentixol—HTR2A—pituitary gland—polycystic ovary syndrome	0.000134	0.028	CbGeAlD
Flupentixol—ABCB1—embryo—polycystic ovary syndrome	0.000132	0.0277	CbGeAlD
Flupentixol—HTR2A—adrenal gland—polycystic ovary syndrome	0.000119	0.025	CbGeAlD
Flupentixol—HTR2A—vagina—polycystic ovary syndrome	0.000111	0.0232	CbGeAlD
Flupentixol—ABCB1—adrenal cortex—polycystic ovary syndrome	0.000108	0.0227	CbGeAlD
Flupentixol—HTR2A—endocrine gland—polycystic ovary syndrome	0.000103	0.0217	CbGeAlD
Flupentixol—ABCB1—endometrium—polycystic ovary syndrome	9.67e-05	0.0203	CbGeAlD
Flupentixol—ABCB1—uterus—polycystic ovary syndrome	8.91e-05	0.0187	CbGeAlD
Flupentixol—ABCB1—pituitary gland—polycystic ovary syndrome	8.75e-05	0.0183	CbGeAlD
Flupentixol—ABCB1—adipose tissue—polycystic ovary syndrome	8.72e-05	0.0183	CbGeAlD
Flupentixol—ABCB1—adrenal gland—polycystic ovary syndrome	7.82e-05	0.0164	CbGeAlD
Flupentixol—ABCB1—female gonad—polycystic ovary syndrome	7.29e-05	0.0153	CbGeAlD
Flupentixol—ABCB1—vagina—polycystic ovary syndrome	7.24e-05	0.0152	CbGeAlD
Flupentixol—ABCB1—endocrine gland—polycystic ovary syndrome	6.78e-05	0.0142	CbGeAlD
Flupentixol—ADRA1A—Signaling by GPCR—GHRL—polycystic ovary syndrome	3.14e-05	0.00019	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	3.1e-05	0.000188	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—GAB1—polycystic ovary syndrome	3.1e-05	0.000188	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	3.08e-05	0.000187	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	3.08e-05	0.000186	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	3.07e-05	0.000186	CbGpPWpGaD
Flupentixol—DDC—Metabolism—PPARG—polycystic ovary syndrome	3.06e-05	0.000185	CbGpPWpGaD
Flupentixol—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	3.04e-05	0.000184	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	3.04e-05	0.000184	CbGpPWpGaD
Flupentixol—DDC—Metabolism—POMC—polycystic ovary syndrome	3.02e-05	0.000183	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—ADRA1A—polycystic ovary syndrome	3.02e-05	0.000183	CbGpPWpGaD
Flupentixol—DDC—Metabolism—INS—polycystic ovary syndrome	3e-05	0.000182	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	3e-05	0.000182	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—FST—polycystic ovary syndrome	2.99e-05	0.000181	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	2.97e-05	0.00018	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—INSR—polycystic ovary syndrome	2.96e-05	0.000179	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—ADRB3—polycystic ovary syndrome	2.95e-05	0.000179	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—FST—polycystic ovary syndrome	2.94e-05	0.000178	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—FST—polycystic ovary syndrome	2.92e-05	0.000177	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	2.92e-05	0.000177	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	2.92e-05	0.000177	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—LHB—polycystic ovary syndrome	2.92e-05	0.000177	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	2.91e-05	0.000176	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—ADRB3—polycystic ovary syndrome	2.9e-05	0.000176	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—ADRB3—polycystic ovary syndrome	2.89e-05	0.000175	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—FST—polycystic ovary syndrome	2.88e-05	0.000174	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—LHB—polycystic ovary syndrome	2.87e-05	0.000174	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	2.86e-05	0.000173	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—LHB—polycystic ovary syndrome	2.85e-05	0.000173	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.85e-05	0.000173	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—ADRB3—polycystic ovary syndrome	2.84e-05	0.000172	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.81e-05	0.00017	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—LHB—polycystic ovary syndrome	2.81e-05	0.00017	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.8e-05	0.00017	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.79e-05	0.000169	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—STAR—polycystic ovary syndrome	2.78e-05	0.000169	CbGpPWpGaD
Flupentixol—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	2.78e-05	0.000169	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.77e-05	0.000168	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.76e-05	0.000167	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	2.75e-05	0.000167	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.75e-05	0.000166	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—PGR—polycystic ovary syndrome	2.74e-05	0.000166	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—SCT—polycystic ovary syndrome	2.73e-05	0.000165	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.72e-05	0.000164	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	2.71e-05	0.000164	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.7e-05	0.000164	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	2.7e-05	0.000163	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	2.7e-05	0.000163	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—SCT—polycystic ovary syndrome	2.69e-05	0.000163	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—SCT—polycystic ovary syndrome	2.67e-05	0.000162	CbGpPWpGaD
Flupentixol—DRD2—Circadian rythm related genes—IL6—polycystic ovary syndrome	2.67e-05	0.000162	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.66e-05	0.000161	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	2.65e-05	0.000161	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	2.65e-05	0.000161	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	2.64e-05	0.00016	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—SCT—polycystic ovary syndrome	2.63e-05	0.000159	CbGpPWpGaD
Flupentixol—CHRM1—Circadian rythm related genes—IL6—polycystic ovary syndrome	2.61e-05	0.000158	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.61e-05	0.000158	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	2.6e-05	0.000157	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.57e-05	0.000155	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—FGF18—polycystic ovary syndrome	2.56e-05	0.000155	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.55e-05	0.000154	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—PLAT—polycystic ovary syndrome	2.55e-05	0.000154	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—GHRL—polycystic ovary syndrome	2.55e-05	0.000154	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—RBP4—polycystic ovary syndrome	2.54e-05	0.000154	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—FGF18—polycystic ovary syndrome	2.52e-05	0.000153	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.51e-05	0.000152	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—FGF18—polycystic ovary syndrome	2.51e-05	0.000152	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—GNAS—polycystic ovary syndrome	2.5e-05	0.000151	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—RBP4—polycystic ovary syndrome	2.5e-05	0.000151	CbGpPWpGaD
Flupentixol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	2.49e-05	0.000151	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	2.49e-05	0.000151	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—RBP4—polycystic ovary syndrome	2.49e-05	0.000151	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	2.48e-05	0.00015	CbGpPWpGaD
Flupentixol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	2.48e-05	0.00015	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—FGF18—polycystic ovary syndrome	2.47e-05	0.000149	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—GNAS—polycystic ovary syndrome	2.46e-05	0.000149	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—POMC—polycystic ovary syndrome	2.46e-05	0.000149	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—GNAS—polycystic ovary syndrome	2.45e-05	0.000148	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—RBP4—polycystic ovary syndrome	2.45e-05	0.000148	CbGpPWpGaD
Flupentixol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	2.44e-05	0.000148	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—ATF1—polycystic ovary syndrome	2.43e-05	0.000147	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—GNAS—polycystic ovary syndrome	2.41e-05	0.000146	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.37e-05	0.000144	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—YAP1—polycystic ovary syndrome	2.37e-05	0.000144	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	2.37e-05	0.000143	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.36e-05	0.000143	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—GAB1—polycystic ovary syndrome	2.34e-05	0.000142	CbGpPWpGaD
Flupentixol—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	2.34e-05	0.000141	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—YAP1—polycystic ovary syndrome	2.33e-05	0.000141	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—YAP1—polycystic ovary syndrome	2.32e-05	0.000141	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—GAB1—polycystic ovary syndrome	2.3e-05	0.000139	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—GAB1—polycystic ovary syndrome	2.29e-05	0.000139	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—YAP1—polycystic ovary syndrome	2.28e-05	0.000138	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—GAB1—polycystic ovary syndrome	2.25e-05	0.000136	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—NGFR—polycystic ovary syndrome	2.25e-05	0.000136	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—INSR—polycystic ovary syndrome	2.24e-05	0.000135	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—POMC—polycystic ovary syndrome	2.23e-05	0.000135	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—PRL—polycystic ovary syndrome	2.22e-05	0.000135	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—INSR—polycystic ovary syndrome	2.2e-05	0.000133	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—INSR—polycystic ovary syndrome	2.19e-05	0.000133	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—LHB—polycystic ovary syndrome	2.16e-05	0.000131	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—INSR—polycystic ovary syndrome	2.15e-05	0.00013	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.14e-05	0.00013	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.13e-05	0.000129	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.11e-05	0.000128	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	2.11e-05	0.000128	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.09e-05	0.000127	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.09e-05	0.000127	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.08e-05	0.000126	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—PGR—polycystic ovary syndrome	2.07e-05	0.000125	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.06e-05	0.000125	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.05e-05	0.000124	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.05e-05	0.000124	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	2.04e-05	0.000124	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—PGR—polycystic ovary syndrome	2.04e-05	0.000123	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—PGR—polycystic ovary syndrome	2.03e-05	0.000123	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.02e-05	0.000122	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—PGR—polycystic ovary syndrome	2e-05	0.000121	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—GNAS—polycystic ovary syndrome	1.96e-05	0.000119	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—GHRL—polycystic ovary syndrome	1.93e-05	0.000117	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—PLAT—polycystic ovary syndrome	1.93e-05	0.000117	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—PLAT—polycystic ovary syndrome	1.89e-05	0.000115	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—GHRL—polycystic ovary syndrome	1.89e-05	0.000115	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—GHRL—polycystic ovary syndrome	1.88e-05	0.000114	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—PLAT—polycystic ovary syndrome	1.88e-05	0.000114	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	1.88e-05	0.000114	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.86e-05	0.000113	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—PLAT—polycystic ovary syndrome	1.85e-05	0.000112	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—GHRL—polycystic ovary syndrome	1.85e-05	0.000112	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.85e-05	0.000112	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—ATF1—polycystic ovary syndrome	1.84e-05	0.000111	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—NRG1—polycystic ovary syndrome	1.83e-05	0.000111	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.82e-05	0.000111	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	1.82e-05	0.00011	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.82e-05	0.00011	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—ATF1—polycystic ovary syndrome	1.81e-05	0.000109	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—ATF1—polycystic ovary syndrome	1.8e-05	0.000109	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.79e-05	0.000108	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.79e-05	0.000108	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.78e-05	0.000108	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—ATF1—polycystic ovary syndrome	1.77e-05	0.000107	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.76e-05	0.000107	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	1.76e-05	0.000106	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.75e-05	0.000106	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.75e-05	0.000106	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.74e-05	0.000106	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.73e-05	0.000104	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.72e-05	0.000104	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—NGFR—polycystic ovary syndrome	1.69e-05	0.000103	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	1.69e-05	0.000102	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—POMC—polycystic ovary syndrome	1.68e-05	0.000102	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—PRL—polycystic ovary syndrome	1.68e-05	0.000102	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—NGFR—polycystic ovary syndrome	1.67e-05	0.000101	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	1.67e-05	0.000101	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—NGFR—polycystic ovary syndrome	1.66e-05	0.0001	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—POMC—polycystic ovary syndrome	1.66e-05	0.0001	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—PRL—polycystic ovary syndrome	1.65e-05	0.0001	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—POMC—polycystic ovary syndrome	1.65e-05	9.98e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—PRL—polycystic ovary syndrome	1.64e-05	9.95e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—NGFR—polycystic ovary syndrome	1.63e-05	9.89e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—POMC—polycystic ovary syndrome	1.62e-05	9.83e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.62e-05	9.8e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—PRL—polycystic ovary syndrome	1.62e-05	9.8e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.59e-05	9.65e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.59e-05	9.65e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.58e-05	9.59e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	1.57e-05	9.53e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.57e-05	9.49e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—IRS2—polycystic ovary syndrome	1.57e-05	9.49e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.56e-05	9.44e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.56e-05	9.44e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	1.55e-05	9.38e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.54e-05	9.3e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—LEP—polycystic ovary syndrome	1.53e-05	9.29e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—GNAS—polycystic ovary syndrome	1.48e-05	8.95e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—GNAS—polycystic ovary syndrome	1.45e-05	8.8e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—GNAS—polycystic ovary syndrome	1.45e-05	8.76e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—GNAS—polycystic ovary syndrome	1.42e-05	8.62e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.41e-05	8.52e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.39e-05	8.39e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—NRG1—polycystic ovary syndrome	1.38e-05	8.37e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.38e-05	8.34e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—IRS1—polycystic ovary syndrome	1.37e-05	8.29e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—NRG1—polycystic ovary syndrome	1.36e-05	8.23e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.36e-05	8.21e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—NRG1—polycystic ovary syndrome	1.35e-05	8.19e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—TH—polycystic ovary syndrome	1.34e-05	8.11e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—NRG1—polycystic ovary syndrome	1.33e-05	8.06e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—POMC—polycystic ovary syndrome	1.32e-05	7.98e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—INS—polycystic ovary syndrome	1.31e-05	7.94e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	1.3e-05	7.89e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—IGF1—polycystic ovary syndrome	1.27e-05	7.68e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—AKT2—polycystic ovary syndrome	1.27e-05	7.67e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	1.23e-05	7.42e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.2e-05	7.29e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—IRS2—polycystic ovary syndrome	1.18e-05	7.17e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—IRS2—polycystic ovary syndrome	1.16e-05	7.05e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—IRS2—polycystic ovary syndrome	1.16e-05	7.01e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—LEP—polycystic ovary syndrome	1.16e-05	7.01e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—IRS2—polycystic ovary syndrome	1.14e-05	6.9e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—LEP—polycystic ovary syndrome	1.14e-05	6.9e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—LEP—polycystic ovary syndrome	1.13e-05	6.86e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—LEP—polycystic ovary syndrome	1.12e-05	6.76e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	1.09e-05	6.62e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	1.04e-05	6.31e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—IRS1—polycystic ovary syndrome	1.03e-05	6.26e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—IRS1—polycystic ovary syndrome	1.02e-05	6.16e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—IRS1—polycystic ovary syndrome	1.01e-05	6.12e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—IRS1—polycystic ovary syndrome	9.95e-06	6.03e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—POMC—polycystic ovary syndrome	9.95e-06	6.02e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—INS—polycystic ovary syndrome	9.89e-06	5.99e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	9.88e-06	5.98e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—POMC—polycystic ovary syndrome	9.79e-06	5.93e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—POMC—polycystic ovary syndrome	9.74e-06	5.9e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—INS—polycystic ovary syndrome	9.74e-06	5.9e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—IL6—polycystic ovary syndrome	9.69e-06	5.87e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—INS—polycystic ovary syndrome	9.68e-06	5.86e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—POMC—polycystic ovary syndrome	9.59e-06	5.8e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—IGF1—polycystic ovary syndrome	9.57e-06	5.8e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—AKT2—polycystic ovary syndrome	9.56e-06	5.79e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—INS—polycystic ovary syndrome	9.53e-06	5.77e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—IGF1—polycystic ovary syndrome	9.42e-06	5.7e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—AKT2—polycystic ovary syndrome	9.41e-06	5.7e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—IGF1—polycystic ovary syndrome	9.37e-06	5.67e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—AKT2—polycystic ovary syndrome	9.36e-06	5.67e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—IGF1—polycystic ovary syndrome	9.22e-06	5.58e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—AKT2—polycystic ovary syndrome	9.21e-06	5.58e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	9.21e-06	5.58e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	9.09e-06	5.5e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.94e-06	5.41e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.89e-06	5.39e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.76e-06	5.3e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.28e-06	5.01e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	7.47e-06	4.52e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—POMC—polycystic ovary syndrome	7.37e-06	4.46e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—INS—polycystic ovary syndrome	7.32e-06	4.44e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—IL6—polycystic ovary syndrome	7.32e-06	4.43e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—IL6—polycystic ovary syndrome	7.2e-06	4.36e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	7.16e-06	4.34e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—IL6—polycystic ovary syndrome	7.05e-06	4.27e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.25e-06	3.79e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.15e-06	3.72e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.12e-06	3.7e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.02e-06	3.65e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—IL6—polycystic ovary syndrome	5.73e-06	3.47e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—IL6—polycystic ovary syndrome	4.32e-06	2.62e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—IL6—polycystic ovary syndrome	4.25e-06	2.58e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—IL6—polycystic ovary syndrome	4.23e-06	2.56e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—IL6—polycystic ovary syndrome	4.17e-06	2.52e-05	CbGpPWpGaD
